Ultragenyx Pharmaceutical RARE
$16.48 −$0.74 (-4.30%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.50 +0.12%
Open$16.94
Prev close$17.22
Day range$16.43 – $17.35
Volume3.01M
Market cap$1.68B
P/E (TTM)–
Dividend yield–
RARE Stock News
Headlines matching Ultragenyx Pharmaceutical or the RARE ticker, most recent first.
- American Rare Earths Ltd: CSM Study Strengthens Foundation for U.S. REE Supply
- Ord Minnett Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Sell Rating, Cuts Target Price to $9.82 Negative
- JX Advanced Metals: Notice Regarding the Agreement on a Joint Study for Entering the Rare Earth Refining Business with Tronox Co., Ltd.
- H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $25 Negative
- H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $25
- Citi Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $22
- A Quick Look at Today's Ratings for Ultragenyx Pharmaceutical(RARE.US), With a Forecast Between $22 to $36
- Rare Element Resources Ltd. | 10-Q: Quarterly report
- A Quick Look at Today's Ratings for Ultragenyx Pharmaceutical(RARE.US), With a Forecast Between $17 to $36
- BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Hold Rating, Maintains Target Price $20
- TD Cowen Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Hold Rating, Cuts Target Price to $9.79 Negative
- BMO Capital Initiates LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Announces Target Price $11.95
- Northland Securities Maintains USA Rare Earth(USAR.US) With Buy Rating, Cuts Target Price to $20 Negative
- China Rare Earth Nonferrous: Notice of China Rare Earth Nonferrous Metals Co., Ltd. on Convening the Third Extraordinary Shareholders' Meeting of 2026
- Roth MKM Maintains USA Rare Earth(USAR.US) With Buy Rating, Cuts Target Price to $20 Negative
No comments yet — be the first to weigh in on RARE.
Sign in to join the discussion.